Bandy Barton P.'s Form 4 filing
Vyome Holdings, Inc (HIND) · filed Sep 17, 2021
- Accession no.
- 0001790300-21-000011
- Filed
- Sep 17, 2021
- Trade date
- Jul 22-Sep 10, 2021
- Filing delay
- 57 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $851.1K. It was filed 57 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bandy Barton P.CIK 0001773309 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 22, 2021 | Common Stock, $0.001 par value per share | AGrant or awardAcquired | +960,100 | $0.00 | $0 | 960,100 | Direct | |
| Jul 22, 2021 | Common Stock, $0.001 par value per share | AGrant or awardAcquired | +225,906 | $0.00 | $0 | 1,186,006 | Direct | |
| Sep 10, 2021 | Common Stock, $0.001 par value per share | SSaleDisposed | −294,494 | $2.89F4 | −$851,087.66 | 891,512 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F4
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.88 to $2.90, inclusive. The Reporting Person undertakes to provide to ReShape Lifesciences Inc., any security holder of ReShape Lifesciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
Referenced by the price of 1 transaction in Table I.